Namely, the interaction between tumor-infiltrating lymphocytes (TIL) PD-1 and PD-L1 expressed on the surface of both tumor cells and other leukocytes triggers molecular pathways leading to reduced immune cell function [3]. This evidence concerns the gene CD274 and neoplasm.